![]() |
市場調查報告書
商品編碼
1558274
到 2030 年高級傷口敷料市場預測:按產品類型、傷口類型、分銷管道、最終用戶和地區進行的全球分析Advanced Wound Dressings Market Forecasts to 2030 - Global Analysis By Product Type (Alginates, Collagens, Foams, Hydrocolloids, Hydrofibres, Hydrogels and Other Product Types), Wound Type, Distribution Channel, End User and By Geography |
根據 Stratistics MRC 的數據,2024 年全球先進傷口敷料市場規模為 78 億美元,預計在預測期內將以 7.6% 的複合年成長率成長,到 2030 年達到 121 億美元。
先進的傷口敷料是一種專門的醫療材料,旨在促進複雜傷口的癒合過程。與傳統敷料不同,它透過保持濕度、促進細胞遷移和預防感染為創傷治療提供最佳環境。這些敷料通常用於慢性傷口,如糖尿病潰瘍、褥瘡和燒傷。它們含有水凝膠、藻酸鹽、發泡體和親水膠體等成分,具有水合作用、滲出液管理和免受外部污染物侵害等優點,可改善患者的治療效果。
根據《傷口管理與預防》2022年發表的報導,預計到2060年,65歲及以上的老年人口將增加25.0%,對高級創傷護理的需求將持續成長。
手術次數增加
外科手術的增加推動了對先進傷口敷料的需求,因為它們是術後護理所必需的專用材料。隨著手術數量的增加,對有效傷口管理解決方案的需求也在增加,以加速癒合、降低感染風險並提高患者舒適度。具有優異水分控制和保護性能的高性能傷口敷料在外科傷口管理的臨床環境中越來越受到青睞,為市場成長做出了重大貢獻。
恢復時間長
較長的恢復時間可能會增加醫療成本並降低患者的依從性,對市場產生負面影響。較長的癒合時間需要頻繁更換敷料,這可能會導致醫療資源緊張並增加患者的財務負擔。此外,長時間的康復會增加患者的不滿並降低對先進創傷護理解決方案的信任。由於醫療保健提供者和患者都尋求更有效率、更具成本效益的選擇,這些因素可能會減緩市場成長。
轉向先進的傷口管理
醫療保健提供者擴大採用創新的創傷護理解決方案,以增強傳統敷料的癒合能力。這種轉變是由於需要更有效地管理慢性傷口、改善患者治療效果和縮短住院時間而推動的。先進的傷口敷料因其卓越的水分管理、感染預防和促進癒合效果而被選擇,從而帶來顯著的市場成長和創新。
高成本
高市場成本是採用的主要障礙,特別是在資源匱乏的環境。這種專用敷料的成本可能會限制患者和醫療保健提供者的可及性,並導致對更實惠的傳統替代品的依賴。這些成本因素也會導致醫療保健預算緊張,並抑制先進解決方案的使用,儘管它們具有臨床益處。因此,市場成長可能會受到阻礙,特別是在注重成本效益的醫療保健的地區。
COVID-19 的疫情對市場產生了各種影響。儘管擇期手術和常規就診被推遲,對創傷護理產品的需求減少,但疫情凸顯了有效傷口管理在預防院內感染的重要性。儘管供應鏈中斷和醫療支出減少最初減緩了市場成長,但在疫情期間對感染控制和家庭創傷護理的日益關注最終支持了市場復甦。
預計親水膠體產業將成為預測期內最大的細分市場
預計親水膠體在預測期內將佔最大佔有率。這些敷料由果膠和明膠等凝膠形成劑組成,可吸收傷口滲出物,同時形成對污染物的保護屏障。其自黏特性和柔韌性使其非常適合傷口護理,包括褥瘡和燒燙傷。由於其功效和患者舒適度,親水膠體對親水膠體的日益偏好正在推動市場成長。
預計醫院領域在預測期內的複合年成長率最高。
預計醫院領域在預測期內的複合年成長率最高。隨著外科手術量的增加以及人們越來越關注減少醫院感染,醫院正在投資先進的創傷護理解決方案。這些敷料具有卓越的癒合特性和感染控制能力,對於改善患者治療效果、縮短復原時間和降低整體醫療成本至關重要,從而推動市場成長。
預計北美在預測期內將佔據最大的市場佔有率。該地區先進的醫療基礎設施和對創新創傷護理解決方案的關注進一步支持了市場擴張。隨著人們對先進敷料的益處(包括促進癒合和預防感染)的認知不斷提高,需求持續成長。此外,支持先進創傷護理的政府措施和報銷政策也鼓舞了該地區的市場前景。
預計亞太地區在預測期內複合年成長率最高。糖尿病和肥胖等慢性病的盛行率不斷上升是一個主要促進因素。這些疾病通常會導致慢性傷口等併發症,需要先進的創傷護理解決方案。該地區醫療保健支出的增加正在推動先進創傷護理產品的採用。這種趨勢在醫療基礎建設發達的國家尤其明顯。
According to Stratistics MRC, the Global Advanced Wound Dressings Market is accounted for $7.8 billion in 2024 and is expected to reach $12.1 billion by 2030 growing at a CAGR of 7.6% during the forecast period. Advanced wound dressings are specialized medical materials designed to enhance the healing process of complex wounds. Unlike traditional dressings, they provide an optimal environment for wound healing by maintaining moisture, promoting cell migration, and preventing infection. These dressings are typically used for chronic wounds such as diabetic ulcers, pressure sores, and burns. They may include components like hydrogels, alginates, foams, and hydrocolloids, which offer benefits such as moisture retention, exudate management, and protection from external contaminants, thereby improving patient outcomes.
According to an article published by Wound Management & Prevention in 2022, the demand for advanced wound care will continue to grow as the population older than 65 years is projected to increase by 25.0% by 2060.
Increasing surgical procedures
The rise in surgical procedures is driving the demand for advanced wound dressings, as these specialized materials are essential for post-operative care. As the number of surgeries increases, so does the need for effective wound management solutions that can promote faster healing, reduce infection risk, and improve patient comfort. Advanced wound dressings, with their superior moisture control and protective properties, are increasingly preferred in clinical settings to manage surgical wounds, contributing significantly to the growth of the market.
Long recovery times
Long recovery times can negatively impact the market by increasing healthcare costs and reducing patient compliance. Extended healing periods may lead to a higher demand for frequent dressing changes, which can strain healthcare resources and increase the financial burden on patients. Additionally, prolonged recovery can result in patient dissatisfaction and decreased trust in advanced wound care solutions. These factors may slow market growth as both healthcare providers and patients seek more efficient and cost-effective alternatives.
Shift to advanced wound management
Healthcare providers are increasingly adopting innovative wound care solutions that offer enhanced healing benefits over traditional dressings. This shift is driven by the need for more effective management of chronic wounds, improved patient outcomes, and reduced hospital stays. Advanced wound dressings, with their superior moisture control, infection prevention, and accelerated healing properties, are becoming the preferred choice, leading to substantial market growth and innovation.
High costs
High costs in the market pose a significant barrier to widespread adoption, particularly in low-resource settings. The expense of these specialized dressings can limit accessibility for patients and healthcare providers, leading to reliance on more affordable, traditional alternatives. This cost factor may also strain healthcare budgets, discouraging the use of advanced solutions despite their clinical benefits. As a result, market growth could be hampered, especially in regions where cost-effective care is a priority.
The COVID-19 pandemic had a mixed impact on the market. While elective surgeries and routine healthcare visits were delayed, reducing the demand for wound care products, the pandemic also highlighted the importance of effective wound management in preventing hospital-acquired infections. Supply chain disruptions and reduced healthcare spending initially slowed market growth, but the increasing focus on infection control and home-based wound care during the pandemic ultimately supported a recovery in the market.
The hydrocolloids segment is expected to be the largest during the forecast period
The hydrocolloids is expected to be the largest during the forecast period. These dressings, composed of gel-forming agents like pectin or gelatin, absorb wound exudate while forming a protective barrier against contaminants. Their self-adherent and flexible nature makes them ideal for treating various wound types, including pressure ulcers and burns. The rising preference for hydrocolloids, due to their effectiveness and patient comfort, is driving market growth.
The hospitals segment is expected to have the highest CAGR during the forecast period
The hospitals segment is expected to have the highest CAGR during the forecast period. With an increasing number of surgical procedures and a growing focus on reducing hospital-acquired infections, hospitals are investing in advanced wound care solutions. These dressings, with their superior healing properties and infection control, are essential in improving patient outcomes, reducing recovery times, and lowering overall healthcare costs, thus fueling market growth.
North America is projected to hold the largest market share during the forecast period. The region's advanced healthcare infrastructure and strong focus on innovative wound care solutions further support market expansion. With rising awareness of the benefits of advanced dressings, including faster healing and infection prevention, demand continues to grow. Additionally, government initiatives and reimbursement policies favoring advanced wound care contribute to the market's positive outlook in the region.
Asia Pacific is projected to witness the highest CAGR over the forecast period. The increasing incidence of chronic conditions such as diabetes and obesity is a significant driver. These diseases often lead to complications like chronic wounds, necessitating advanced wound care solutions. Increased healthcare spending in the region is facilitating the adoption of advanced wound care products. This trend is particularly notable in countries with improving healthcare infrastructure.
Key players in the market
Some of the key players in Advanced Wound Dressings market include 3M Co., B. Braun Melsungen AG, BSN Medical GmbH, Coloplast A/S, ConvaTec Group Plc, Molnlycke Health Care AB, Smith & Nephew Plc, Cardinal Health, Medline Industries, Integra Life Sciences, Advanced Medical Solutions, Argentum Medical, LLC, Fidia Farmaceutici, DeRoyal Industries, Essity, Human BioSciences Inc. and Sanara MedTech Inc.
In January 2024, Medline Industries, LP launched its first transparent wound dressing for pressure injury prevention with an aim to widen its product offerings.
In April 2024, Smith+Nephew announced a recent study to support the ALLEVYN LIFE Foam Dressing with an aim to strengthen its presence in the advanced wound management segment globally.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.